ArticleActa anaesthesiologica Scandinavica2019
Continued licensing of hydroxyethyl starch despite high-quality data documenting harm in vulnerable patient populations: A sad day for patient safety.
Jon Henrik Laake et al.PubMed ↗Publisher ↗
No numbers read from the abstract.